{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-031919","form_type":"8-K","ticker":"XAIR","cik":"0001641631","company_name":"Beyond Air, Inc.","filed_at":"2023-09-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.654227+00:00","generated_at":"2026-06-10T22:52:12.054397+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Beyond Air Enters Distribution Agreement with Getz Healthcare for LungFit PH in Asia-Pacific","bullets":["Getz Healthcare to make $1,000,000 milestone payment upon CE mark certification of LungFit PH in Europe.","Beyond Air receives ongoing royalty payments on net sales starting at low double-digits and peaking at 20%.","Partnership covers 10 Asia-Pacific countries including Australia, New Zealand, Thailand, Philippines, Taiwan, Hong Kong, Malaysia, Pakistan, Singapore, and Vietnam.","BTIG, LLC acted as financial advisor to Beyond Air for the agreement.","LungFit PH is currently FDA-approved for neonates with hypoxic respiratory failure in the U.S. only."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-031919","json":"https://secwatch.observer/filing/0001493152-23-031919.json","markdown":"https://secwatch.observer/filing/0001493152-23-031919.md","text":"https://secwatch.observer/filing/0001493152-23-031919.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641631/000149315223031919/0001493152-23-031919-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641631/000149315223031919/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T22:52:12.054397+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}